Clinical trial
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical…
NCT00407030 · Merz Pharmaceuticals GmbH, Industry · Completed
Key facts
| NCT number | NCT00407030 |
|---|---|
| Title | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia |
| Official title | Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Trial With a Double-blind Parallel-group Extension Period to Investigate the Efficacy and Safety of Different Doses of IncobotulinumtoxinA (Xeomin) in the Treatment of Cervical Dystonia |
| Lead sponsor | Merz Pharmaceuticals GmbH, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Dystonia |
| Intervention type | Drug |
| Interventions | incobotulinumtoxinA (Xeomin) (240 Units), incobotulinumtoxinA (Xeomin) (120 Units), Placebo |
| Enrollment | 233 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jun 1, 2009 |
| First posted | Dec 4, 2006 |
| Last update posted | Jul 19, 2013 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: